Chorea-acanthocytosis: A Case Report with Review of Oral Manifestations

Aadithya B Urs1, Jeyaseelan Augustine1, Azhar Ahmed Khan1

  • 1Department of Oral and Maxillofacial Pathology, Maulana Azad Institute of Dental Sciences, New Delhi, India.

Insights

Chorea-acanthocytosis (ChAc) is a rare genetic neurological disorder. This case highlights its oral manifestations, including tongue and cheek biting, linked to the VPS13A gene mutation.

Area of Science:

  • Neurogenetics
  • Cell Biology
  • Hematology

Background:

  • Chorea-acanthocytosis (ChAc) is a rare, autosomal recessive neurodegenerative disorder.
  • It results from mutations in the VPS13A gene, impacting protein sorting and cell membrane stability.
  • This leads to characteristic neurological symptoms and distinct red blood cell morphology (acanthocytes).

Observation:

  • A 47-year-old male with a history of neurological issues presented with oral ulcerations.
  • Clinical examination revealed chorea, dystonia, impaired gait, and elevated creatinine kinase.
  • The patient exhibited frequent tongue and cheek biting, indicative of orofacial dystonia.

Findings:

  • Molecular genetic testing confirmed a mutation in the VPS13A gene, diagnosing Chorea-acanthocytosis.
  • The patient's physical presentation included involuntary movements (chorea, dystonia) and gait disturbances.
  • Oral manifestations, specifically self-inflicted cheek and tongue trauma, were prominent features.

Implications:

  • This case underscores the importance of recognizing oral manifestations in the diagnosis of ChAc.
  • Understanding the link between VPS13A mutations and orofacial dystonia can improve patient management.
  • Highlighting rare disease presentations aids in broader clinical awareness and diagnostic capabilities.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
238
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
398
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.2K
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
117
Direct-Acting Cholinergic Agonists: Therapeutic Uses01:11

Direct-Acting Cholinergic Agonists: Therapeutic Uses

Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
1.2K
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
210